Published in Medical Imaging Business Week, June 23rd, 2005
The collaboration with BioCurex and the Center for Cancer Care is long term and will consist of three phases: The first one will continue and expand the applications of our serum and biopsy tests using RECAF.
The second phase will focus on imaging applications using RECAF to detect the location of cancerous tumors in the body. The third phase includes clinical trials in which RECAF will be used as a way to specifically deliver therapeutic agents to destroy the cancer cells with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.